Derazantinib dihydrochloride is a salt form of Derazantinib, a pan-FGFR inhibitor. It has demonstrated preliminary anti-tumor activity in research models of FGFR2 fusion-positive intrahepatic cholangiocarcinoma (iCCA), supporting its investigation in both in vitro and in vivo oncology studies.
Molekulargewicht:
541.49
CAS Nummer:
[1821329-75-2]
Formel:
C29H31Cl2FN4O
Target-Kategorie:
EGFR,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten